Table 3 Rate of CVC utilization rate, CLABSI incidence and mortality
From: Multi-center prospective study on central line-associated bloodstream infections in 79 ICUs of China
Year | 2014 | 2015 | 2016 | 2017 | 2018 | P value for trend test |
|---|---|---|---|---|---|---|
No. of hospitalization days | 271,383 | 231,437 | 215,747 | 205,648 | 164,707 | Ā |
No. of device days | 120,595 | 100,367 | 93,466 | 86,141 | 66,016 | Ā |
No. of patients with CLABSI | 159 | 119 | 151 | 164 | 109 | Ā |
No. of death with CLABSI | 32 | 31 | 27 | 27 | 10 | Ā |
Utilization rate of CVCs, % M (Q1, Q2, Q3) | 44.44 (32.46, 44.28, 58.27) | 43.37 (31.42, 45.86, 61.45) | 43.32 (32.13, 44.71, 60.57) | 41.89 (30.06, 39.47, 53.82) | 40.08 (21.29, 35.68, 45.46) | .000 |
CLABSI rate, per 1000 catheter-days M (Q1, Q2, Q3) | 1.32 (.00, .87, 1.75) | 1.19 (.00, .34, 1.62) | 1.62 (.00, .97, 1.67) | 1.9 (.39, 1.24, 1.89) | 1.65 (.00, 1.00, 1.77) | .000 |
Mortality, % M (Q1, Q2, Q3) | 20.13 (.00, 12.12, 33.33) | 26.05 (.00, 10.00, 33.33) | 17.88 (.00, 16.67, 33.33) | 16.46 (.00, .00, 33.33) | 9.17 (.00, .00, 22.22) | 0.024 |